MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas (NCT06712875)
OrganizationBiotech
Ann & Robert H Lurie Children's Hospital of Chicago
Organization linked by public source evidence.
Public IDs
No public external ID is attached.
Related people
No reviewed person affiliation is attached.
Outputs
No reviewed output is linked through affiliated people.
Topics
Relationship evidence
Timeline
No dated relationship evidence is attached.